Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $32.03 $45.00 Thursday, 9th May 2024 CRBP stock ended at $43.74. This is 3.18% more than the trading day before Wednesday, 8th May 2024. During the day the stock fluctuated 3.47% from a day low at $42.34 to a day high of $43.81.
90 days $20.87 $49.87
52 weeks $3.03 $49.87

Historical Corbus Pharmaceuticals Holdings prices

Date Open High Low Close Volume
Nov 23, 2016 $8.15 $8.15 $7.50 $8.00 1 458 014
Nov 22, 2016 $8.00 $8.15 $7.30 $7.95 2 605 852
Nov 21, 2016 $6.80 $8.30 $6.80 $7.85 1 862 697
Nov 18, 2016 $7.05 $7.20 $6.80 $6.95 824 896
Nov 17, 2016 $7.70 $7.90 $6.75 $7.00 1 724 370
Nov 16, 2016 $8.25 $8.70 $7.45 $7.80 1 316 398
Nov 15, 2016 $8.00 $9.25 $7.65 $8.15 2 322 303
Nov 14, 2016 $9.85 $10.30 $7.70 $8.85 12 692 057
Nov 11, 2016 $5.85 $6.40 $5.30 $5.85 744 536
Nov 10, 2016 $6.60 $6.75 $5.90 $6.05 886 646
Nov 09, 2016 $5.80 $6.85 $5.70 $6.45 1 172 527
Nov 08, 2016 $5.50 $5.75 $5.45 $5.70 745 897
Nov 07, 2016 $5.00 $5.60 $4.97 $5.45 1 198 400
Nov 04, 2016 $4.85 $5.05 $4.75 $4.80 619 000
Nov 03, 2016 $5.00 $5.25 $4.75 $4.80 849 100
Nov 02, 2016 $5.35 $5.49 $4.75 $5.05 898 000
Nov 01, 2016 $5.70 $5.70 $5.25 $5.28 592 800
Oct 31, 2016 $5.10 $5.80 $4.65 $5.60 2 533 500
Oct 28, 2016 $5.90 $6.10 $5.08 $5.25 1 840 100
Oct 27, 2016 $6.40 $6.70 $5.75 $5.90 1 991 200
Oct 26, 2016 $7.25 $7.40 $6.13 $6.45 1 554 300
Oct 25, 2016 $6.90 $7.50 $6.00 $7.25 5 139 800
Oct 24, 2016 $9.10 $9.40 $8.50 $8.90 1 872 800
Oct 21, 2016 $7.40 $9.00 $7.25 $8.95 2 140 800
Oct 20, 2016 $7.90 $7.90 $7.00 $7.30 1 787 300
Click to get the best stock tips daily for free!

About Corbus Pharmaceuticals Holdings

Corbus Pharmaceuticals Holdings Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, focuses on the development of immune modulators for immuno-oncology and fibrosis diseases. It develops lenabasum, an oral molecule that selectively activates cannabinoid receptor type 2 (CB2), which is in Phase II clinical trial to treat systemic lupus erythematosus; CRB-601, an anti-integrin monoclonal antibody (mAb) for the treatment of cancer and fibrosis that inhibits the act... CRBP Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT